Book Value per Share: Treace Medical Concepts, Inc. (TMCI)

Graphic logo of Treace Medical (TMCI)

Treace Medical Concepts (TMCI) generates revenue through the implementation of proprietary Lapiplasty techniques for correcting foot pathologies, helping patients accelerate rehabilitation. Exclusive patents on 3D systems and strict FDA oversight ensure a high barrier to entry. The current metric stands at 1.05. The current price action below confirms the brand's status as an authoritative expert in orthopedics, enjoying the unconditional trust of the professional community.

Treace Medical - TMCI Net Assets per Share (period 07/04/2022 - 10/27/2026)

Summary analytical data breakdowns for treace.com (TMCI)

- price and consensus price forecast:
Stock Price Treace Medical|TMCI - Consensus Target
- market capitalization data:
Market Capitalization Treace Medical Concepts, Inc.|TMCI - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Treace Medical Concepts|TMCI - Book Valuation of Business|Market Value to Book Value Ratio treace.com|TMCI - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital Treace Medical Concepts|TMCI - Long-Term Liabilities to Capital|Short-Term Debt to Capital Treace Medical Concepts, Inc.|TMCI - Company Total Debt|Debts to Book Capitalization Treace Medical Concepts, Inc.
Analysis of all company metrics:Treace Medical TMCI
Finished products of treace.com

Book value per share is calculated as the ratio of a company's equity to the number of outstanding shares, reflecting the actual volume of net assets per share. Monitoring book value data allows for the timely detection of asset impairment, which is critical for Treace Medical Concepts (TMCI) amid the modernization of production lines and the procurement of expensive precision equipment.

Competitors of Treace Medical Concepts (TMCI)

BSX: Book Value per Share|EW - Accounting Value per Share|ResMed Inc. - Book Value per Share|PODD (insulet.com) - Net Assets per Share|ZBH: Net Assets per Single Share|Net Assets per Share COO|ALGN - Net Assets per Single Share|Share Book Value NuVasive (GMED)|TMDX: Book Value per Share|Net Asset Value per Share atecspine.com ATEC|AORT: Book Value per Share|ENOV - Accounting Value per Share|Integra - Book Value per Share|Establishment Labs Inc (ESTA) - Net Assets per Share|BBNX (Beta Bionics Inc) - Book Value per Share|Book Value per Share IRMD|Net Assets per Single Share Embecta (EMBC)|Net Assets per Single Share Tandem Diabetes Care Inc (TNDM)|Book Value per Share AXGN|SIBN - Net Assets per Share|Accounting Value per Share Orthofix Medical Inc.|BVS - Share Book Value|Book Value per Share KIDS|Blade Air Mobility (SRTA) - Net Asset Value per Share|Book Value per Share Carlsmed Corp (CARL)|Equity per Share RxSight Ophthalmic (RXST)|ClearPoint Neuro, Inc. (CLPT) - Accounting Value per Share|Accounting Value of a Share STXS (stereotaxis.com)|Neuronetics - Net Assets per Single Share|Accounting Value per Share Sight Sciences Inc. SGHT|OBIO (Orchestra BioMed, Inc.) - Book Value per Share|ANIK - Net Asset Value per Share|Book Value per Share InspireMD, Inc.|Jin Medical (ZJYL) - Equity per Share|VANI: Book Value per Share|Net Assets per Share Xtant Medical Inc|Book Value per Share NMTC (NeuroOne Corp)|Accounting Value per Share modular-medical.com (MODD)|Book Value per Share MYO (Myomo, Inc.)|envoymedical.com - Book Value per Share|VVOS - Net Assets per Single Share|enVVeno Medical Corporation (NVNO) - Net Assets per Single Share|Accounting Value per Share sintx.com SINT|Tenon Medical Inc (TNON) - Accounting Value of a Share|Book Value per Share LFWD (ReWalk Robotics Ltd.)|Net Asset Value per Share AMIX|IVF: Net Assets per Single Share|Book Value of One Share Bone Biologics Corp. BBLG|Accounting Value per Share AXNX (Axonics Modulation Technologies)|Book Value per Share Biolase Inc. BIOL|Book Value per Share DYNT (Dynatronics Corp.)|FNA: Net Assets per Share|Net Assets per Single Share invobioscience.com (INVO)